Search

Internet addiction (IA), as a new and often unrecognized psychosocial disorder, endangers people’s health and their lives. However, the common biometric analysis based on the combination of EEG signals and results of questionnaires is not quantitative, and thus difficult to ensure a specific biomarker. This work aims to develop a deep learning algorithm (no need to identify biomarkers) used for diagnosing IA and evaluating therapy efficacy. Herein, a five-layer CNN model combined with a fast Fourier transform is proposed to diagnose IA quantitatively. This algorithm is validated in the Lemon dataset by using it to process raw data, full spectral power, and alpha-beta-gamma spectral power (related to IA). In contrast to alpha-beta-gamma spectral power, the results based on full spectral power show better performance (87.59% accuracy, 88.80% sensitivity, and 86.41% specificity), which confirms that the proposed algorithm can diagnose IA without biomarkers. In addition, this proposed CNN model presents obvious advantages in processing raw data, achieving 81.1% accuracy. Such results verify that this method can contribute to the reduction of diagnosis time and be potentially used in real-time health monitoring systems. This work provides a quantitative approach to diagnose IA and evaluate therapy efficacy, as a general strategy, and can be widely used in other disorder diagnoses that affect EEG signals, such as psychiatric disorders, substance dependence, and depression.

Cold atmospheric plasma (CAP) is a promising tool to overcome certain cancerous and precancerous conditions in dermatology. A scheme of transferred CAP was first developed to treat melanoma (B16F10) skin cancer cells as well as non-malignant (L929) cells in vitro. CAP was transferred using a silicone tube with a jet system that was developed and was assessed as to whether it could generate reactive oxygen and nitrogen species (RONS) at near-room temperature. The transferred CAP was characterized electrically and spectroscopically. Biological data showed that the transferred CAP killed cancer cells but not non-malignant (L929) cells. Plasma treatment was effective with a time duration of 30 s, whereas non-malignant (L929) cells were less damaged during plasma treatment. In addition, catalase (CAT) enzyme was applied to neutralize and detoxify the RONS generated by the transferred CAP. These findings suggest that transferred CAP can be considered a melanoma cancer therapy.